(Q34909055)

English

A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease

scientific article

Statements

A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit